what does bafna pharmaceuticals do

Bafna Pharmaceuticals Limited is a pharmaceutical company that manufactures finished pharmaceutical formulations, specializing in non-betalactam solid oral dosage forms, and operates with EU-GMP, UK MHRA, and TGA Australia accreditations to supply high-quality products to regulated markets.

what products does bafna pharmaceuticals make

The company produces a range of finished pharmaceutical formulations, including non-betalactam solid oral dosage forms, though specific product details are not provided in the context.

what sector is bafna pharmaceuticals in

Bafna Pharmaceuticals Limited operates in the pharmaceutical sector, focusing on manufacturing and selling finished pharmaceutical formulations in India.

when was bafna pharmaceuticals founded

Bafna Pharmaceuticals Limited was incorporated in 1981.

who owns bafna pharmaceuticals

Bafna Pharmaceuticals Limited is a publicly listed company on the BSE and NSE, and while ownership is not specified, it is available for public investment through these stock exchanges.

Bafna Pharmaceuticals Limited (BAFNAPH) Share Price Today — ₹168.15

Bafna Pharmaceuticals Limited (BAFNAPH) live stock price is ₹168.15. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Bafna Pharmaceuticals Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Bafna Pharmaceuticals Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

BAFNAPH

BSE

Bafna Pharmaceuticals Limited

Healthcare· Pharmaceuticals & Biotechnology· INE878I01022· Scrip: 532989

EN हिन्दी ગુજરાતી मराठी

₹168.15

▲ 8.80 (+0.00%)

2026-06-10

BSE

₹168.15

▲ 8.80

+0.00%

233 trading days · 1Y period

TODAY (BSE)

Open168.15

High168.15

Low168.15

Prev Close176.95

Volume405

Value₹0.0Cr

L: 168.15H: 168.15

Info

Face Value₹10

Listed2020-02-27

ISININE878I01022

SeriesT

BSE Scrip532989

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue-17.70%

PAT-63.79%

EPS-63.96%

Profitability

EBITDA Margin9.8%

Net Margin2.9%

TTM EBITDA M.8.7%

TTM Net M.2.9%

Dividend

Yield—

Latest DPS—

Payout Ratio—

Growth—

TTM Revenue

₹148 Cr

TTM EBITDA

₹13 Cr

TTM PAT

₹4 Cr

TTM EPS

₹1.82

Rev/Share

₹62.6

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	33 Cr	32 Cr	3 Cr	1 Cr	1 Cr	₹0.40
2024-09-30	40 Cr	39 Cr	5 Cr	3 Cr	3 Cr	₹1.11
2024-06-30	33 Cr	34 Cr	1 Cr	-1 Cr	-1 Cr	₹-0.31
2024-03-31	41 Cr	40 Cr	3 Cr	1 Cr	1 Cr	₹0.62
2023-12-31	28 Cr	32 Cr	-1 Cr	-3 Cr	-3 Cr	₹-1.24
2023-09-30	41 Cr	38 Cr	4 Cr	2 Cr	2 Cr	₹1.05
2023-06-30	42 Cr	37 Cr	8 Cr	6 Cr	6 Cr	₹2.68
2023-03-31	42 Cr	37 Cr	8 Cr	6 Cr	5 Cr	₹2.34

Shareholding Pattern

CURRENT — 2026-03-31

Promoter75.0%

FII9.3%

Public25.0%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2024-09-17	Other	Annual General Meeting
2022-07-20	Other	Annual General Meeting
2021-08-05	Other	Annual General Meeting
2020-07-23	Other	Annual General Meeting

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	165.86	165.86	165.86	165.86	24,824
2026-06-03	152.68	152.68	152.68	152.68	2,326
2026-05-27	130.16	136.66	125.00	129.90	3,645
2026-05-26	135.84	139.40	129.05	130.16	6,142
2026-05-25	139.00	140.80	135.50	135.84	1,390
2026-05-22	141.80	142.33	133.01	135.03	2,530
2026-05-21	139.05	140.00	133.41	135.84	2,143
2026-05-20	136.40	138.50	133.50	138.36	2,064
2026-05-19	137.40	138.00	133.05	134.69	1,207
2026-05-18	134.90	140.90	134.90	135.30	234
2026-05-15	135.00	141.60	135.00	135.30	1,101
2026-05-14	139.05	144.50	133.00	135.90	4,105
2026-05-13	133.00	139.60	133.00	138.60	3,678
2026-05-12	135.45	139.40	133.00	133.00	4,711
2026-05-11	133.99	136.00	126.70	135.45	4,640
2026-05-08	132.00	132.00	131.00	132.00	430
2026-05-07	131.10	134.00	130.00	131.22	3,189
2026-05-06	134.00	134.00	131.00	131.10	975
2026-05-05	131.10	135.00	130.81	134.19	227
2026-05-04	133.33	137.90	130.15	134.93	3,407
2026-04-30	136.00	136.00	130.01	134.00	867
2026-04-29	138.80	138.80	130.55	131.84	3,210
2026-04-28	133.40	136.32	129.00	132.97	3,844
2026-04-27	136.02	137.38	130.10	133.53	1,690
2026-04-24	134.00	138.80	134.00	136.02	609
2026-04-23	132.00	138.73	127.10	137.02	5,431
2026-04-22	133.00	134.00	130.55	132.13	2,475
2026-04-21	138.40	138.40	131.00	136.45	1,402
2026-04-20	143.00	143.00	132.55	133.57	4,146
2026-04-17	138.00	139.45	126.30	139.45	4,521

Frequently Asked Questions

About

Bafna Pharmaceuticals Limited, listed on the National Stock Exchange, is a pharmaceutical company primarily focused on manufacturing and marketing a range of generic and specialty medicines. Its key products include formulations for cardiovascular, central nervous system, and anti-infective diseases, with a notable emphasis on affordable healthcare solutions. The company, founded in 1999, has maintained a significant promoter stake of 75% and has demonstrated consistent profitability despite not distributing dividends to shareholders.